Atrial Fibrillation Also called: AF, Afib

Clinical Trial Finder

Many patients with atrial fibrillation are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

SL-AF Trial - (Six Lead Identification of Atrial Fibrillation [AF])

Condition:   Atrial Fibrillation
Intervention:   Device: RhythmPadGP
Sponsor:   Cardiocity Limited
Recruiting - verified March 2015

The Vanderbilt Atrial Fibrillation Ablation Registry

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Vanderbilt University
Recruiting - verified March 2015

Left Atrial Volume Index in Asymptomatic Aortic Stenosis

Conditions:   Aortic Valve Stenosis;   Heart Failure
Intervention:  
Sponsor:   Odense University Hospital
Recruiting - verified March 2015

Topera E-FIRM Registry

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   I-Med-Pro GmbH;   Topera, Inc.
Recruiting - verified March 2015

Cerebral Oxygen Saturation Measurement During Cardioversion Because of Atrial Fibrillation

Conditions:   Electrical Cardioversion of Atrial Fibrillation;   Pharmacological Cardioversion of Atrial Fibrillation
Intervention:   Device: SenSmart Model X-100, Nonin Medical
Sponsor:   Hasselt University
Recruiting - verified March 2015

Comparison of Success Rate of Totally Thoracoscopic Ablation Versus Hybrid Procedure in Patients With Persistent Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:   Procedure: Eletrophysiologic study
Sponsor:   Samsung Medical Center
Recruiting - verified March 2015

Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder

Conditions:   Elderly;   Hypertension;   Risk Factors for Atrial Fibrillation
Intervention:  
Sponsors:   Population Health Research Institute;   Bristol-Myers Squibb;   Pfizer;   M-Health Solutions
Active, not recruiting - verified March 2015

Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention

Condition:   Atrial Fibrillation
Intervention:   Drug: Rivaroxaban
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified March 2015

Rate Control in Atrial Fibrillation: A Randomized, Double-Blind, Crossover Comparison of Carvedilol and Metoprolol Tartrate

Condition:   Atrial Fibrillation
Interventions:   Drug: Carvedilol;   Drug: Metoprolol tartrate
Sponsor:   Creighton University
Not yet recruiting - verified March 2015

Prediction of Fluid Responsiveness in Atrial Fibrillation Patients Who Underwent Valvular Heart Surgery: Peep-induced Increase in Central Venous Pressure vs. Passive Leg Raising

Condition:   Valvular Heart Surgery
Interventions:   Procedure: peep induced CVP;   Procedure: passive leg raising(PLR)
Sponsor:   Yonsei University
Completed - verified March 2015

Genotype-guided Warfarin Individualized Treatment

Conditions:   Atrial Fibrillation;   Deep Venous Thrombosis
Interventions:   Behavioral: Genotype-guided dosing algorithm for warfarin;   Behavioral: Standard initiation dose for warfarin
Sponsor:   The Third Xiangya Hospital of Central South University
Recruiting - verified October 2014

Safety and Performance of a GLOBAL Mapping and Ablation Device for the Treatment of Atrial Fibrillation (GLOBAL-AF)

Condition:   Atrial Fibrillation
Intervention:   Device: Global mapping and ablation device
Sponsor:   Kardium Inc.
Recruiting - verified March 2015

A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

Condition:   Paroxysmal Atrial Fibrillation
Interventions:   Drug: BMS-919373;   Drug: Placebo (Matching with BMS-919373)
Sponsor:   Bristol-Myers Squibb
Recruiting - verified October 2014

Treatment of Atrial Fibrillation in Patients by Pulmonary Vein Isolation, Renal Artery Denervation or Both.

Conditions:   Paroxysmal Atrial Fibrillation;   Persistent Atrial Fibrillation;   Hypertension
Intervention:   Procedure: procedure
Sponsor:   Diagram B.V.
Recruiting - verified March 2015

ECG Derived Respiration for Automated Screening of Sleep Disordered Breathing in Chronic Heart Failure Patients

Conditions:   Heart Failure;   Sleep Apnea Syndromes;   Polysomnography
Intervention:   Device: ventilatory polygraphic recordings
Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
Completed - verified March 2015

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Drug: edoxaban;   Drug: Enoxaparin;   Drug: Warfarin
Sponsors:   Daiichi Sankyo Inc.;   Covance;   Quintiles
Recruiting - verified March 2015

Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

Condition:   Atrial Fibrillation
Interventions:   Drug: Apixaban;   Drug: Parenteral heparin and/or oral Vitamin K antagonist
Sponsors:   Pfizer;   Bristol-Myers Squibb
Recruiting - verified March 2015

Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified March 2015

Stroke Feasibility Study

Conditions:   Atrial Fibrillation;   AFib
Intervention:   Device: AtriClip LAA Exclusion Device
Sponsor:   AtriCure, Inc.
Active, not recruiting - verified March 2015

The Effect of Early Repeat Atrial Fibrillation (AF) Ablation on AF Recurrence

Condition:   Atrial Fibrillation
Intervention:   Procedure: Repeat PVI
Sponsors:   Liverpool Heart and Chest Hospital NHS Foundation Trust;   Biosense Webster, Inc.
Active, not recruiting - verified March 2015

Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)

Conditions:   Cardiothoracic Surgery;   Post-operative Atrial Fibrillation
Interventions:   Drug: Atorvastatin 20 mg;   Drug: Atorvastatin 80 mg
Sponsor:   Creighton University
Recruiting - verified March 2015

Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)

Condition:   Paroxysmal Atrial Fibrillation
Interventions:   Procedure: PVI Ablation;   Procedure: FIRM Ablation
Sponsors:   Indiana University;   University of California, Los Angeles;   Indiana University Health/Indiana University School of Medicine Strategic Research Initiative;   Topera, Medical
Terminated - verified March 2015

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

Condition:   Hypertrophic Cardiomyopathy
Intervention:   Other: None - this is an observational study
Sponsors:   University of Virginia;   National Heart, Lung, and Blood Institute (NHLBI);   Oxford University Hospitals NHS Trust
Recruiting - verified March 2015

Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)

Condition:   Non-valvular Atrial Fibrillation
Intervention:   Drug: Apixaban
Sponsor:   Bristol-Myers Squibb
Recruiting - verified December 2014

Effectiveness Study of Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   La-ser Europe Limited
Recruiting - verified March 2015

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region

Condition:   Atrial Fibrillation
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor:   Bayer
Recruiting - verified March 2015

Colchicine and CRP in Atrial Fibrillation and AF Ablation

Condition:   Atrial Fibrillation
Interventions:   Drug: Colchicine, 0.6 mg PO BID;   Drug: Matching placebo
Sponsor:   Mayo Clinic
Recruiting - verified March 2015

Rivaroxaban Laboratory Monitoring in Switzerland 2: Therapeutic Dose (RivaMoS 2)

Condition:   Healthy
Intervention:  
Sponsors:   Prof. Dr. Dr. med. Walter A. Wuillemin, MD, PhD;   Research Foundation, Division of Hematology, Luzerner Kantonsspital, Switzerland;   Bayer (Schweiz) AG, Switzerland
Completed - verified March 2015

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

Condition:   Atrial Fibrillation
Intervention:   Other: Patients with Atrial Fibrillation
Sponsors:   Janssen Scientific Affairs, LLC;   Duke Clinical Research Institute
Recruiting - verified March 2015

Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Monitor

Condition:   Atrial Fibrillation
Intervention:   Device: Implantable Cardiac Monitor (Confirm(R)ICM model 2102)
Sponsors:   Population Health Research Institute;   St. Jude Medical;   Canadian Institutes of Health Research  (CIHR)
Recruiting - verified March 2015

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified March 2015

Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)

Condition:   Atrial Fibrillation
Intervention:   Device: Ablation procedure staged catheter ablation
Sponsor:   AtriCure, Inc.
Active, not recruiting - verified March 2015

Systematic ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm and Halland, Sweden

Conditions:   Atrial Fibrillation;   Stroke
Intervention:   Other: ECG screening for atrial fibrillation
Sponsor:   Karolinska University Hospital
Active, not recruiting - verified March 2015

CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM

Condition:   Coronary Artery Disease
Intervention:   Device: CorMatrix extra cellular matrix (ECM)
Sponsors:   Inova Health Care Services;   CorMatrix Cardiovascular, Inc.
Active, not recruiting - verified March 2015

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified March 2015

Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial Fibrillation

Conditions:   Heart Failure;   Atrial Fibrillation
Interventions:   Procedure: Rhythm control;   Other: Rate Control
Sponsors:   Ottawa Heart Institute Research Corporation;   Canadian Institutes of Health Research  (CIHR)
Recruiting - verified July 2014

Electrocardiogram Variations in the Prediction of Development of Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Hospital Italiano de Buenos Aires
Completed - verified March 2015

Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:   Other: No Amiodarone
Sponsor:   Inova Health Care Services
Active, not recruiting - verified March 2015

Atrial Fibrillation Ablation The Hybrid Approach Versus Traditional Management

Condition:   Ablation of Atrial Fibrillation
Interventions:   Procedure: Pulmonary vein isolation ablation procedure for atrial fibrillation;   Procedure: Hybrid procedure for ablation of atrial fibrillation;   Procedure: The Cox Maze Procedure for Ablation of Atrial Fibrillation;   Procedure: Hybrid Procedure for Left Atrium >5 cm but < 6.1 cm
Sponsor:   Inova Health Care Services
Withdrawn - verified March 2015

Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting

Conditions:   Ischemic Heart Disease;   Atrial Fibrillation
Interventions:   Drug: Omega-3 fish oil emulsion (Omegaven);   Drug: Intralipid
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Terminated - verified March 2015

PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin.

Condition:   Stroke
Interventions:   Drug: Dalteparin;   Other: Placebo
Sponsors:   Lawson Health Research Institute;   Canadian Institutes of Health Research  (CIHR);   Pfizer
Recruiting - verified March 2015

A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:   Procedure: Bipolar radiofrequency ablation
Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital;   Oslo University Hospital;   Haukeland Sykehus HF;   Ullevaal University Hospital;   Regionssykehuset i Tromsø HF;   Feiringklinikken
Withdrawn - verified March 2015

Get CardioSmart

You're Invited

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points